175 related articles for article (PubMed ID: 36064388)
1. Promoter methylation of transient receptor potential melastatin-related 7 (TRPM7) predicts a better prognosis in patients with Luminal A breast cancers.
Wang Y; Lu R; Chen P; Cui R; Ji M; Zhang X; Hou P; Qu Y
BMC Cancer; 2022 Sep; 22(1):951. PubMed ID: 36064388
[TBL] [Abstract][Full Text] [Related]
2. Transient Receptor Potential Melastatin 7 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma.
Nakashima S; Shiozaki A; Ichikawa D; Hikami S; Kosuga T; Konishi H; Komatsu S; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Otsuji E
Anticancer Res; 2017 Mar; 37(3):1161-1167. PubMed ID: 28314277
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Oncogenic Roles of the TRPM7 Chanzyme.
Gautier M; Perrière M; Monet M; Vanlaeys A; Korichneva I; Dhennin-Duthille I; Ouadid-Ahidouch H
Curr Med Chem; 2016; 23(36):4092-4107. PubMed ID: 27604090
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Prognostic Values of TRPM7 in Colon and Rectal Cancers.
Lee JC; Bae AN; Lee HJ; Lee JH
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363540
[TBL] [Abstract][Full Text] [Related]
5. Transient receptor potential melastatin-related 7 channel is overexpressed in human pancreatic ductal adenocarcinomas and regulates human pancreatic cancer cell migration.
Rybarczyk P; Gautier M; Hague F; Dhennin-Duthille I; Chatelain D; Kerr-Conte J; Pattou F; Regimbeau JM; Sevestre H; Ouadid-Ahidouch H
Int J Cancer; 2012 Sep; 131(6):E851-61. PubMed ID: 22323115
[TBL] [Abstract][Full Text] [Related]
6. Suppression of TRPM7 Inhibited Hypoxia-Induced Migration and Invasion of Androgen-Independent Prostate Cancer Cells by Enhancing RACK1-Mediated Degradation of HIF-1
Yang F; Cai J; Zhan H; Situ J; Li W; Mao Y; Luo Y
Oxid Med Cell Longev; 2020; 2020():6724810. PubMed ID: 32215176
[TBL] [Abstract][Full Text] [Related]
7. The Transient Receptor Potential Melastatin 7 Channel Regulates Pancreatic Cancer Cell Invasion through the Hsp90α/uPA/MMP2 pathway.
Rybarczyk P; Vanlaeys A; Brassart B; Dhennin-Duthille I; Chatelain D; Sevestre H; Ouadid-Ahidouch H; Gautier M
Neoplasia; 2017 Apr; 19(4):288-300. PubMed ID: 28284058
[TBL] [Abstract][Full Text] [Related]
8. The Role of TRPM7 in Oncogenesis.
Köles L; Ribiczey P; Szebeni A; Kádár K; Zelles T; Zsembery Á
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255793
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic role and therapeutic target of transient receptor potential melastatin 7 channel in malignancy.
Zhou W; Guo S; Xiong Z; Liu M
Expert Opin Ther Targets; 2014 Oct; 18(10):1177-96. PubMed ID: 25069584
[TBL] [Abstract][Full Text] [Related]
10. Suppression of TRPM7 enhances TRAIL-induced apoptosis in triple-negative breast cancer cells.
Song C; Choi S; Oh KB; Sim T
J Cell Physiol; 2020 Dec; 235(12):10037-10050. PubMed ID: 32468675
[TBL] [Abstract][Full Text] [Related]
11. Transient receptor potential melastatin 7 is involved in oestrogen receptor-negative metastatic breast cancer cells migration through its kinase domain.
Guilbert A; Gautier M; Dhennin-Duthille I; Rybarczyk P; Sahni J; Sevestre H; Scharenberg AM; Ouadid-Ahidouch H
Eur J Cancer; 2013 Nov; 49(17):3694-707. PubMed ID: 23910495
[TBL] [Abstract][Full Text] [Related]
12. Carvacrol affects breast cancer cells through TRPM7 mediated cell cycle regulation.
Li L; He L; Wu Y; Zhang Y
Life Sci; 2021 Feb; 266():118894. PubMed ID: 33310045
[TBL] [Abstract][Full Text] [Related]
13. TRPM7 and its role in neurodegenerative diseases.
Sun Y; Sukumaran P; Schaar A; Singh BB
Channels (Austin); 2015; 9(5):253-61. PubMed ID: 26218331
[TBL] [Abstract][Full Text] [Related]
14. TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth.
Gao SL; Kong CZ; Zhang Z; Li ZL; Bi JB; Liu XK
Oncol Rep; 2017 Oct; 38(4):1967-1976. PubMed ID: 28791418
[TBL] [Abstract][Full Text] [Related]
15. Silencing TRPM7 in mouse cortical astrocytes impairs cell proliferation and migration via ERK and JNK signaling pathways.
Zeng Z; Leng T; Feng X; Sun H; Inoue K; Zhu L; Xiong ZG
PLoS One; 2015; 10(3):e0119912. PubMed ID: 25799367
[TBL] [Abstract][Full Text] [Related]
16. Evidence that TRPM7 is required for breast cancer cell proliferation.
Guilbert A; Gautier M; Dhennin-Duthille I; Haren N; Sevestre H; Ouadid-Ahidouch H
Am J Physiol Cell Physiol; 2009 Sep; 297(3):C493-502. PubMed ID: 19515901
[TBL] [Abstract][Full Text] [Related]
17. TRPM7 Regulates AKT/FOXO1-Dependent Tumor Growth and Is an Independent Prognostic Indicator in Renal Cell Carcinoma.
Zhao Z; Zhang M; Duan X; Chen Y; Li E; Luo L; Wu W; Peng Z; Qiu H; Zeng G
Mol Cancer Res; 2018 Jun; 16(6):1013-1023. PubMed ID: 29545479
[TBL] [Abstract][Full Text] [Related]
18. TRPM7 is required for ovarian cancer cell growth, migration and invasion.
Wang J; Liao QJ; Zhang Y; Zhou H; Luo CH; Tang J; Wang Y; Tang Y; Zhao M; Zhao XH; Zhang QY; Xiao L
Biochem Biophys Res Commun; 2014 Nov; 454(4):547-53. PubMed ID: 25450691
[TBL] [Abstract][Full Text] [Related]
19. Transient receptor potential melastatin 7 and their modulators.
Cheng XY; Li SF; Chen Y; Zhao YJ; Hu W; Lu C; Zhou RP
Eur J Pharmacol; 2022 Sep; 931():175180. PubMed ID: 35940237
[TBL] [Abstract][Full Text] [Related]
20. Cell death modulation by transient receptor potential melastatin channels TRPM2 and TRPM7 and their underlying molecular mechanisms.
Shi R; Fu Y; Zhao D; Boczek T; Wang W; Guo F
Biochem Pharmacol; 2021 Aug; 190():114664. PubMed ID: 34175300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
